An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
Saved in:
| Title: | An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. |
|---|---|
| Authors: | Jackson JW; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Hall BL; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Sneiderman C; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Webb A; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA., Hancock TJ; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Vlasyuk M; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Bailey L; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Xiaokui M; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA., Solomon IH; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Ligon K; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Goins WF; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Kohanbash G; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Chiocca EA; Harvey W. Cushing Neuro-oncology Laboratories (HCNL), Department of Neurosurgery, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA., Glorioso JC; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2025 Aug 06; Vol. 33 (3), pp. 201030. Date of Electronic Publication: 2025 Aug 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41394271 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jackson+JW%22">Jackson JW</searchLink>; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA.<br /><searchLink fieldCode="AU" term="%22Hall+BL%22">Hall BL</searchLink>; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Sneiderman+C%22">Sneiderman C</searchLink>; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Webb+A%22">Webb A</searchLink>; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Hancock+TJ%22">Hancock TJ</searchLink>; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA.<br /><searchLink fieldCode="AU" term="%22Vlasyuk+M%22">Vlasyuk M</searchLink>; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA.<br /><searchLink fieldCode="AU" term="%22Bailey+L%22">Bailey L</searchLink>; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Xiaokui+M%22">Xiaokui M</searchLink>; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Solomon+IH%22">Solomon IH</searchLink>; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Ligon+K%22">Ligon K</searchLink>; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Goins+WF%22">Goins WF</searchLink>; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Kohanbash+G%22">Kohanbash G</searchLink>; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Chiocca+EA%22">Chiocca EA</searchLink>; Harvey W. Cushing Neuro-oncology Laboratories (HCNL), Department of Neurosurgery, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Glorioso+JC%22">Glorioso JC</searchLink>; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2025 Aug 06; Vol. 33 (3), pp. 201030. <i>Date of Electronic Publication: </i>2025 Aug 06 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41394271 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omton.2025.201030 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 201030 Titles: – TitleFull: An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jackson JW – PersonEntity: Name: NameFull: Hall BL – PersonEntity: Name: NameFull: Sneiderman C – PersonEntity: Name: NameFull: Webb A – PersonEntity: Name: NameFull: Hancock TJ – PersonEntity: Name: NameFull: Vlasyuk M – PersonEntity: Name: NameFull: Bailey L – PersonEntity: Name: NameFull: Xiaokui M – PersonEntity: Name: NameFull: Solomon IH – PersonEntity: Name: NameFull: Ligon K – PersonEntity: Name: NameFull: Goins WF – PersonEntity: Name: NameFull: Kohanbash G – PersonEntity: Name: NameFull: Chiocca EA – PersonEntity: Name: NameFull: Glorioso JC IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 08 Text: 2025 Aug 06 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2950-3299 Numbering: – Type: volume Value: 33 – Type: issue Value: 3 Titles: – TitleFull: Molecular therapy. Oncology Type: main |
| ResultId | 1 |
